InCrowd
InCrowd was a real-time market intelligence platform for the life sciences industry, headquartered in Watertown, Massachusetts, launched in March 2011 by a team of three co-founders. InCrowd was one of three healthcare research firms unified into Konovo in April 2025.
About InCrowd
InCrowd was a real-time market intelligence platform for the life sciences industry, headquartered in Watertown, Massachusetts, launched in March 2011 by a team of three co-founders. InCrowd described itself as the pioneer of real-time, automated market research for life sciences - connecting clients directly with prescribers, patients, and other screened and validated healthcare professionals through short, 2-5 minute online "microsurveys," with insights delivered in hours or days rather than weeks. At its peak reach, InCrowd's platform connected clients to 1.8 million healthcare professionals worldwide in 20 languages, via products including MicroTracker, MicroQual, and GlobalTranslate.
By the time of its 2019 acquisition, InCrowd served more than 100 life sciences clients across 300+ brands, including 18 of the top 20 pharmaceutical companies.
In September 2019, InCrowd was acquired by SARORAS Private Capital, becoming the founding company of what would become Apollo Intelligence (later renamed Konovo). InCrowd was one of three healthcare research firms — alongside Survey Healthcare Global and GlocalMind — unified into the Konovo brand in April 2025.
FAQ
Is InCrowd still an independent company? No. InCrowd was acquired in 2019, becoming the founding company of Apollo Intelligence, which was unified with two other healthcare research firms into Konovo in April 2025.
What did InCrowd specialize in? InCrowd specialized in real-time market research for life sciences, using a proprietary "microsurvey" methodology to deliver insights from healthcare professionals within hours or days rather than weeks.
